Corticosteroids reduce pacemaker implantation after alcohol septal ablation in oHCM patients
In this retrospective analysis, post-procedural corticosteroid administration was associated with a significant reduction in the need for permanent pacemaker implantation in oHCM patients with CHB after ASA. Further research is needed to confirm these findings and establish optimal corticosteroid treatment protocols.
Authors
- Volker Rudolph (ORCID: https://orcid.org/0000-0001-5385-6839)
- Max Potratz (ORCID: https://orcid.org/0000-0003-4044-7037)
- Smita Scholtz (ORCID: https://orcid.org/0000-0002-7445-5986)
- Lothar Faber (ORCID: https://orcid.org/0000-0003-3298-764X)
- Jan‐Christian Reil (ORCID: https://orcid.org/0000-0003-1053-5175)
- Kawa Mohemed
- Charles J. Davidson
- Cédric Coppée
Institutions
- Northwestern University (US)
- Heart and Diabetes Center North Rhine-Westphalia (DE)
- Lukaskrankenhaus (DE)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1007/s00392-025-02752-y
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00